Yousefi Y, Nejati R, Eslahi A, Alizadeh F, et al. Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O(6)-methylguanine DNA methyltransferase (MGMT). J Neurooncol 2024;169:129-135.
PMID: 38762829